Drug recall · February 14, 2018
Megestrol Acetate Oral Suspension recall
Why: Subpotent Drug: Out of specification for assay (stability testing)
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
- Lots / codes
Lot #: 0114588, Exp 10/18
- Quantity
- 24120 cups
- Company
- Mckesson Packaging Services, Concord, NC
- Distribution
- U.S.A. Nationwide
- Initiated
- January 29, 2018 · Voluntary: Firm initiated
- Classified
- February 8, 2018
- Reported
- February 14, 2018
- Ended
- November 24, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Megestrol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.